Matches in SemOpenAlex for { <https://semopenalex.org/work/W2996912398> ?p ?o ?g. }
- W2996912398 endingPage "5078" @default.
- W2996912398 startingPage "5071" @default.
- W2996912398 abstract "BRAF V600E mutation was proved to be associated with thyroid cancer. Papillary thyroid carcinoma (PTC) with positive BRAF mutation might have a more aggressive behavior. We investigated the correlation of the contrast-enhanced ultrasound (CEUS) features with BRAF 600VE in PTC.The medical records of 1,199 patients with 1,315 nodules who underwent CEUS prior to fine needle aspiration (FNA) from January 2016 to March 2018 were retrospectively reviewed. The features of their enhancement were assessed from eight aspects: degree of enhancement, method of enhancement, homogeneity of enhancement, completeness of enhancement, boundary of the enhanced lesions, shape of the enhanced lesions, size of the enhanced lesions, and wash out period of the enhanced lesions. The patients then examined for the BRAF V600E mutation using specimens obtained from FNA.BRAF mutations were found in 888 of 1,315 nodules. The CEUS features were significantly different between BRAF-positive and BRAF-negative nodules. The BRAF mutation positive nodules were more often with larger size, hypo-enhancement, centripetal enhancement, inhomogeneous enhancement, complete enhancement, blurred boundary, irregular shape, and with wash out period at preoperative CEUS than those without BRAF mutations (P<0.001). However, no significant correlation was showed in Spearman's rank correlation between the CEUS features and BRAF mutation, except for degree of enhancement, method pattern of enhancement, and completeness of complete enhancement. Multivariate analysis showed that centripetal (OR: 1.465, 95% CI: 1.129-1.903) and no significant enhancement (OR: 0.790, 95% CI: 0.639-0.977) were predictive for the presence of BRAF mutations. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of no significant enhancement and centripetal enhancement of CEUS for predicting BRAF mutation were 68.3%, 40.0%, 91.6%, 11.7%, and 72.4%, 35.1%, 37.8%, 70.0%, respectively.Our study indicated that preoperative thyroid nodule characteristics on CEUS might serve as a useful tool to BRAF mutation in PTC." @default.
- W2996912398 created "2020-01-10" @default.
- W2996912398 creator A5006835554 @default.
- W2996912398 creator A5027297044 @default.
- W2996912398 creator A5028520423 @default.
- W2996912398 creator A5043608846 @default.
- W2996912398 creator A5051303998 @default.
- W2996912398 creator A5062066172 @default.
- W2996912398 creator A5065107305 @default.
- W2996912398 creator A5071274619 @default.
- W2996912398 creator A5079944301 @default.
- W2996912398 date "2019-12-01" @default.
- W2996912398 modified "2023-09-27" @default.
- W2996912398 title "The features of contrast enhanced ultrasound and BRAF V600E in papillary thyroid carcinoma" @default.
- W2996912398 cites W1538981488 @default.
- W2996912398 cites W1539993673 @default.
- W2996912398 cites W1603230122 @default.
- W2996912398 cites W1853452588 @default.
- W2996912398 cites W1966441376 @default.
- W2996912398 cites W1966870034 @default.
- W2996912398 cites W1977867018 @default.
- W2996912398 cites W1979538859 @default.
- W2996912398 cites W1995219003 @default.
- W2996912398 cites W1998314080 @default.
- W2996912398 cites W2018323504 @default.
- W2996912398 cites W2025370928 @default.
- W2996912398 cites W2026302542 @default.
- W2996912398 cites W2031938065 @default.
- W2996912398 cites W2032628059 @default.
- W2996912398 cites W2034948739 @default.
- W2996912398 cites W2040935952 @default.
- W2996912398 cites W2049925242 @default.
- W2996912398 cites W2053949477 @default.
- W2996912398 cites W2059177279 @default.
- W2996912398 cites W2062493935 @default.
- W2996912398 cites W2098999691 @default.
- W2996912398 cites W2118986295 @default.
- W2996912398 cites W2158734599 @default.
- W2996912398 cites W2159343969 @default.
- W2996912398 cites W2163455037 @default.
- W2996912398 cites W2168378503 @default.
- W2996912398 cites W2209532075 @default.
- W2996912398 cites W2405950107 @default.
- W2996912398 cites W2809731572 @default.
- W2996912398 cites W2906045286 @default.
- W2996912398 doi "https://doi.org/10.21037/jtd.2019.11.78" @default.
- W2996912398 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6988045" @default.
- W2996912398 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32030223" @default.
- W2996912398 hasPublicationYear "2019" @default.
- W2996912398 type Work @default.
- W2996912398 sameAs 2996912398 @default.
- W2996912398 citedByCount "10" @default.
- W2996912398 countsByYear W29969123982020 @default.
- W2996912398 countsByYear W29969123982021 @default.
- W2996912398 countsByYear W29969123982022 @default.
- W2996912398 countsByYear W29969123982023 @default.
- W2996912398 crossrefType "journal-article" @default.
- W2996912398 hasAuthorship W2996912398A5006835554 @default.
- W2996912398 hasAuthorship W2996912398A5027297044 @default.
- W2996912398 hasAuthorship W2996912398A5028520423 @default.
- W2996912398 hasAuthorship W2996912398A5043608846 @default.
- W2996912398 hasAuthorship W2996912398A5051303998 @default.
- W2996912398 hasAuthorship W2996912398A5062066172 @default.
- W2996912398 hasAuthorship W2996912398A5065107305 @default.
- W2996912398 hasAuthorship W2996912398A5071274619 @default.
- W2996912398 hasAuthorship W2996912398A5079944301 @default.
- W2996912398 hasBestOaLocation W29969123981 @default.
- W2996912398 hasConcept C104317684 @default.
- W2996912398 hasConcept C117220453 @default.
- W2996912398 hasConcept C126322002 @default.
- W2996912398 hasConcept C126838900 @default.
- W2996912398 hasConcept C142724271 @default.
- W2996912398 hasConcept C143753070 @default.
- W2996912398 hasConcept C185592680 @default.
- W2996912398 hasConcept C2524010 @default.
- W2996912398 hasConcept C2776470698 @default.
- W2996912398 hasConcept C2779022025 @default.
- W2996912398 hasConcept C2779585989 @default.
- W2996912398 hasConcept C2779761222 @default.
- W2996912398 hasConcept C2781461381 @default.
- W2996912398 hasConcept C2993294228 @default.
- W2996912398 hasConcept C33923547 @default.
- W2996912398 hasConcept C501734568 @default.
- W2996912398 hasConcept C526584372 @default.
- W2996912398 hasConcept C55493867 @default.
- W2996912398 hasConcept C71924100 @default.
- W2996912398 hasConceptScore W2996912398C104317684 @default.
- W2996912398 hasConceptScore W2996912398C117220453 @default.
- W2996912398 hasConceptScore W2996912398C126322002 @default.
- W2996912398 hasConceptScore W2996912398C126838900 @default.
- W2996912398 hasConceptScore W2996912398C142724271 @default.
- W2996912398 hasConceptScore W2996912398C143753070 @default.
- W2996912398 hasConceptScore W2996912398C185592680 @default.
- W2996912398 hasConceptScore W2996912398C2524010 @default.
- W2996912398 hasConceptScore W2996912398C2776470698 @default.
- W2996912398 hasConceptScore W2996912398C2779022025 @default.
- W2996912398 hasConceptScore W2996912398C2779585989 @default.
- W2996912398 hasConceptScore W2996912398C2779761222 @default.